ghk-cu wada status just added tirzepatide (mounjaro) to the 2026 Monitoring Program Rope-a-Dope | The New Yorker

Some people only need an injection every few months

Consequently, GPX4 inhibitors behave as a alternative class of senolytic drugs that kill senescent cells by ferroptosis and can be used to treat senescence-associated diseases such as cancer

Y., Speedy, J., Styles, C

Despite extensive research efforts, currently approved therapies provide only limited symptomatic benefit and do not halt disease progression

2014 follow-up study was retracted in 2025, which means the foundational evidence base has significant integrity concerns that should be weighed carefully

Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review